These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 2778713

  • 41. Stereoselective vascular effects of the (R)- and (S)-enantiomers of propranolol and atenolol.
    Stoschitzky K, Lindner W, Kiowski W.
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):268-72. PubMed ID: 7752652
    [Abstract] [Full Text] [Related]

  • 42. Central noradrenergic activity and the cardiovascular effects of nitroglycerin and amyl nitrate.
    Ma S, Long JP.
    J Cardiovasc Pharmacol; 1992 Feb; 20(5):826-36. PubMed ID: 1280748
    [Abstract] [Full Text] [Related]

  • 43. Passive Cigarette Smoking Impact on Blood Pressure Response to Epinephrine and Felypressin in 1K1C Hypertensive Rats Treated or not with Atenolol.
    Fleury CA, Almeida EPM, Dionisio TJ, Calvo AM, Oliveira GM, Amaral SL, Santos CF, Faria FAC.
    Arq Bras Cardiol; 2020 Feb; 114(2):295-303. PubMed ID: 32215501
    [Abstract] [Full Text] [Related]

  • 44. Comparison of epinephrine and felypressin pressure effects in 1K1C hypertensive rats treated or not with atenolol.
    Fleury CA, Andreo VC, Lomba PC, Dionísio TJ, Amaral SL, Santos CF, Faria FA.
    J Anesth; 2015 Feb; 29(1):56-64. PubMed ID: 24962945
    [Abstract] [Full Text] [Related]

  • 45. [Use of a new beta-blocking agent, ICI-66082].
    Grau Real F, Rodrigo Baeza F.
    Rev Esp Anestesiol Reanim; 1975 May; 22(3):243-8. PubMed ID: 1162152
    [No Abstract] [Full Text] [Related]

  • 46. Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol.
    van Zwieten PA, Timmermans PB.
    J Cardiovasc Pharmacol; 1979 May; 1(1):85-96. PubMed ID: 94385
    [Abstract] [Full Text] [Related]

  • 47. Effect of 2-methyltaurine and its enantiomers on arterial blood pressure.
    Braghiroli D, Truzzi C, Brandoli C, Baraldi M, Gamberini G, Di Bella M.
    Pharmacol Res; 1996 May; 34(1-2):33-6. PubMed ID: 8981553
    [Abstract] [Full Text] [Related]

  • 48. Intracisternal naloxone and cardiac nerve blockade prevent vasodilatation during simulated haemorrhage in awake rabbits.
    Evans RG, Ludbrook J, Potocnik SJ.
    J Physiol; 1989 Feb; 409():1-14. PubMed ID: 2585286
    [Abstract] [Full Text] [Related]

  • 49. Stereoselective accumulation of the beta-receptor blocking drug atenolol by human platelets.
    Walle T, Webb JG, Walle UK, Bagwell EE.
    Chirality; 1991 Feb; 3(6):451-3. PubMed ID: 1812954
    [Abstract] [Full Text] [Related]

  • 50. Central and peripheral hypotensive effects of the optical isomers of nicardipine, a dihydropyridine calcium channel antagonist, in rats.
    Brisac AM, Champéroux P, Lucet B, Laurent S, Schmitt H.
    Eur J Pharmacol; 1988 Jan 27; 146(1):171-4. PubMed ID: 3350056
    [Abstract] [Full Text] [Related]

  • 51. Tissue atenolol levels following chronic beta-adrenoceptor blockade using oral atenolol in dogs.
    Davies MK, McAinsh J.
    J Pharm Pharmacol; 1986 Apr 27; 38(4):316-9. PubMed ID: 2872302
    [Abstract] [Full Text] [Related]

  • 52. Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure.
    Tackett RL, Webb JG, Privitera PJ.
    Science; 1981 Aug 21; 213(4510):911-3. PubMed ID: 7256285
    [Abstract] [Full Text] [Related]

  • 53. [Pharmacodynamic study of 6-amino-2-methyl-2-heptanol hydrochloride (heptaminol hydrochloride or R. P. 2831). I. Action of heptaminol hydrochloride on the cardiovascular and central nervous systems].
    GARRETT J.
    Arch Int Pharmacodyn Ther; 1954 Nov 01; 100(1):17-34. PubMed ID: 14350831
    [No Abstract] [Full Text] [Related]

  • 54. Resetting of the baroreceptors by atenolol in the anaesthetized cat.
    Scott EM, Kirkman E.
    Eur J Pharmacol; 1983 Oct 14; 94(1-2):167-70. PubMed ID: 6653657
    [Abstract] [Full Text] [Related]

  • 55. Permeability of the blood-brain barrier for atenolol studied by positron emission tomography.
    Agon P, Goethals P, Van Haver D, Kaufman JM.
    J Pharm Pharmacol; 1991 Aug 14; 43(8):597-600. PubMed ID: 1681079
    [Abstract] [Full Text] [Related]

  • 56. The regional localisation of a new potent centrally acting antihypertensive agent R 28935 and its less active threo-isomer R29814 in the cat brain.
    Loonen AJ, Soudijn W, Van Rooy HH, Van Wijngaarden I.
    Eur J Pharmacol; 1977 Oct 01; 45(3):281-5. PubMed ID: 336381
    [Abstract] [Full Text] [Related]

  • 57. [Action of thevetin on arterial pressure; preliminary experimental study].
    JAY PEREZ LF.
    Arch Hosp Univ; 1957 Oct 01; 9(5):333-9. PubMed ID: 13510004
    [No Abstract] [Full Text] [Related]

  • 58. Effect of GRK4 genetic variants on blood pressure response to atenolol and cardiovascular outcomes.
    Della-Morte D, Guadagni F, Palmirotta R, Ferroni P, Rundek T.
    Pharmacogenomics; 2013 Jan 01; 14(1):13-4. PubMed ID: 23252944
    [No Abstract] [Full Text] [Related]

  • 59. Progress in the Enantioseparation of β-Blockers by Chromatographic Methods.
    Yang Y, Wang Y, Bao Z, Yang Q, Zhang Z, Ren Q.
    Molecules; 2021 Jan 17; 26(2):. PubMed ID: 33477385
    [Abstract] [Full Text] [Related]

  • 60. Revisiting atenolol as a low passive permeability marker.
    Chen X, Slättengren T, de Lange ECM, Smith DE, Hammarlund-Udenaes M.
    Fluids Barriers CNS; 2017 Oct 31; 14(1):30. PubMed ID: 29089037
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.